These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 563345)

  • 21. Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase.
    Odzak R; Calić M; Hrenar T; Primozic I; Kovarik Z
    Toxicology; 2007 Apr; 233(1-3):85-96. PubMed ID: 16962227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase.
    Acharya J; Gupta AK; Dubey DK; Raza SK
    Eur J Med Chem; 2009 Mar; 44(3):1335-40. PubMed ID: 18396353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholinesterase reactivators. Pyridyl and anilyl trifluoromethyl ketoximes.
    Salvador RL; Saucier M; Simon D; Goyer R
    J Med Chem; 1972 Jun; 15(6):646-50. PubMed ID: 5030933
    [No Abstract]   [Full Text] [Related]  

  • 24. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reactivation of phosphorylated acetylcholinesterase (AChE): quaternary salts of vinylogous pyridinaldoxims (author's transl)].
    Hagedorn I; Hohler W
    Arzneimittelforschung; 1976; 26(8):1515-7. PubMed ID: 1036947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis of potential cholinesterase reactivators and protectors. Aliphatic bis-ammonium-ketoximes].
    Reiner R; Scherer A; Schmidt M; Zimmer G
    Arch Pharm Ber Dtsch Pharm Ges; 1971 Sep; 304(9):660-5. PubMed ID: 5288403
    [No Abstract]   [Full Text] [Related]  

  • 27. [Synthesis of reactivators of phosphorylated acetylcholinesterase of bis-pyridiniumdialdoxime type with a 3-oxapentane connecting chain and their testing in vitro on a model of the enzyme inhibited by chlorpyrifos and methylchlorpyrifos].
    Musílek K; Kuca K; Jun D; Dohnal V; Kim TH; Jung YS; Dolezal M
    Ceska Slov Farm; 2006 May; 55(3):115-9. PubMed ID: 16838488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
    Kuca K; Cabal J; Jun D; Hrabinova M
    Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova JZ; Musilek K; Kuca K
    Toxicol Mech Methods; 2009 Jun; 19(5):346-50. PubMed ID: 19778210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reactivation of phosphorylated acetylcholinesterase. Isomeric bisquaternary salts of pyridine aldoximes].
    Hagedorn I; Stark I; Schoene K; Schenkel H
    Arzneimittelforschung; 1978; 28(11):2055-7. PubMed ID: 582905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
    Worek F; Thiermann H; Szinicz L; Eyer P
    Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative structure-reactivity and structure-toxicity relationships of reactivators of phosphylated acetylcholinesterase.
    Mager PP
    Pharmazie; 1981 Jun; 36(6):450-1. PubMed ID: 7279998
    [No Abstract]   [Full Text] [Related]  

  • 36. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
    Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
    Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of new re-activators of cholinesterase.
    Babska A; Bielski L; Kuczyński L; Respond S; Witek H
    Pol J Pharmacol Pharm; 1973; 25(2):175-80. PubMed ID: 4775873
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
    Lorke DE; Petroianu GA
    J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Potential acetylcholinesterase reactivators. 7. Esters of pyridine-N-oxide carbaldehyde oximes and their quaternary derivatives].
    Schnekenburger J; Heber D
    Arch Pharm (Weinheim); 1975 Jan; 308(1):33-41. PubMed ID: 1119906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.